MPM Oncology Impact Management LP, 10% Owner at SUNESIS PHARMACEUTICALS INC (SNSS), bought 81,500 shares at $2.59 ($226K) on 2017-11-02, disclosed to the SEC on 2017-11-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.59 | 25,300 | $66K | 29.0% |
| 2 | $2.89 | 40,000 | $116K | 51.2% |
| 3 | $2.77 | 16,200 | $45K | 19.9% |
| Total | $2.77 avg | 81,500 | $226K | 100% |
| Filing → |
| HARP | SELL | 2021-04-15 | $1.5M | — | Filing → |
| ITOS | SELL | 2021-04-13 | $6K | — | Filing → |
| ITOS | SELL | 2021-04-09 | $2.5M | — | Filing → |